-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
How important are willingness to participate studies in encouraging patient enrollment in oncology trials?
Anand Shah
Editorial: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Assessment methodologies in sleep medicine clinical trials
Elena A Wood,W Vaughn McCall
Clinical Trail Methodology: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation